• Advanced Medical Optics (AMO; Santa Ana, California) reported from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in San Diego the launch of the WhiteStar Signature phacoemulsification system with Fusion Fluidics. The technology combines AMO's WhiteStar technology with the safety of a fusion dual pump fluidic system. The dual pump responsiveness has the performance of a venturi pump and the control of a peristaltic flow-based pump to provide a stable environment for the surgeon and patient. The system includes a one-step, one-hand cassette, intuitive touch screen and intelligent help feature. AMO makes vision technologies for people of all ages.

• Baxter Healthcare (Deerfield, Illinois) reported on the availability of Hylenex recombinant (hyaluronidase human injection) for the ophthalmology market for use in enhancing the absorption and dispersion of other injected drugs. Baxter says Hylenex is a recombinant hyaluronidase therapeutic product and is available in 1 milliliter single-dose vials containing 150 units of hyaluronidase. Hylenex is indicated as an adjuvant to increase the absorption and dispersion of other injected drugs, as an adjuvant for subcutaneous fluid administration (hypodermoclysis), and as an adjunct in subcutaneous urography for improving resorption of radiopaque agents. Baxter develops therapies for medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma.

• Diagnostic HYBRIDS (Athens, Ohio) reported the release of its D³ IFA enterovirus identification kit for the qualitative identification of enteroviruses in cell culture by immunofluorescence. The kit, for in vitro diagnostic use, utilizes a blend of monoclonal antibodies developed in-house. These antibodies target enterovirus-specific antigens produced after a relatively short incubation period in the company's enterovirus cell system called Super E-Mix, or conventional cells such as primary monkey kidney cells. The D³ kit represents a product design improvement on current identification protocols that employ a non-specific, cellular induced protein that is not induced specifically by enteroviruses. Diagnostic HYBRIDS makes diagnostic and analytical products for a wide range of viral respiratory diseases, herpes virus infections, and other specific viral and thyroid diseases.

• Wright Medical Group (Arlington, Tennessee) reported three product launches within its line of hip solutions: the Dynasty acetabular cup system, Profemur TL stem and Gladiator bipolar system. The systems address patient needs in hip arthroplasty. The Dynasty system combines larger diameter femoral heads with screw fixation both metal and cross-linked polyethylene bearing surface options. The system allows increased range of motion and the likelihood of lowered dislocation rates, benefits that are both attributable to larger head diameters. The Profemur combines modular neck technology with a flat tapered wedge geometry stem. The bone-conserving design of the flat tapered wedge stem offers ease of insertion and greater stability within the femoral canal. The Gladiator features a cross-linked polyethylene bearing surface with an enhanced lock detail. Wright is an orthopedic device company.

• Zoll Medical (Chelmsford, Massachusetts), reported release of a new model of its AutoPulse Non-Invasive Cardiac Support Pump, which can document, store and upload device and patient data. The capability allows uploading of information from as many as four patients to Zoll RescueNet code review or CodeNet software via an infrared communications port on the AutoPulse. The AutoPulse data is combined with manual CPR data, defibrillator and other resuscitation data in a user-friendly code summary format that can document virtually all CPR and resuscitation efforts over an entire event. Quality measures, such as CPR compression depth, rate and interruptions, as well as all AutoPulse use data, are all reviewed. Zoll Medical makes resuscitation devices and related software solutions.